📰 Validus Pharmaceuticals News
Validus Pharmaceuticals News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Validus Pharmaceuticals. Real-time updates on events, politics, business and more.
November 28, 2023
Dublin, Nov. 28, 2023 (GLOBE NEWSWIRE) -- The
July 12, 2023
Major oxycodone market players include Bayer AG, Abbott Laboratories, Merck & Co., Inc., Validus Pharmaceuticals LLC, Teva Pharmaceutical Industries Ltd,...
June 29, 2023
Global Bipolar Disorder Therapeutics Market To Witness Significant Revenue Growth On Back Of Augmenting Demand : Fact.MR
June 29, 2023
Global Bipolar Disorder Therapeutics Market To Witness Significant Revenue Growth On Back Of Augmenting Demand : Fact.MR
June 15, 2023
Dublin, June 15, 2023 (GLOBE NEWSWIRE) -- The "Bipolar Disorder Therapeutics: Global Strategic Business Report" report has been added to ...
April 19, 2023
According to the deep-dive market assessment study by Growth Plus Reports, the global acromegaly market was valued at US$ 1.56 billion in 2022 and is expected to register a revenue CAGR of 7.7% to reach US$ 3.04 billion by 2031.
April 13, 2023
/PRNewswire/ -- The diuretic drugs market size is forecasted to increase by USD 95.64 million from 2021 to 2026, at a CAGR of 5.44%, according to the recent...
January 25, 2023
ANAHEIM, CA, Jan. 24, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of innovative...
January 10, 2023
/PRNewswire/ -- Glenmark Pharmaceuticals Inc., USA (Glenmark) is pleased to announce it has launched Bumetanide Injection USP, 1 mg/4 mL (0.25 mg/mL)...
January 10, 2023
Glenmark Pharmaceuticals Inc., USA has launched Bumetanide Injection USP, 1 mg/4 mL (0.25 mg/mL) SingleDose Vials and 2.5 mg/10 mL (0.25 mg/mL) Multi-Dose Vials, the generic version of Bumex® Injection.